Skip to main content
Caplight Logo









MDClone

MDClone

Private
IsraelAI, Data & Cloud Infrastructurehttps://mdclone.com/

Last Round

Series C

Mar 1, 2022

Total Funding Raised

$109M

Company Overview

MDClone is a healthcare technology company that provides a self-service data analytics platform for healthcare organizations to securely access, explore, and analyze medical data using synthetic data generation.

Sector

AI, Data & Cloud Infrastructure

Verticals

Synthetic Data, Healthcare Analytics, Medical AI, Data Governance

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

synthetic datahealthcare analyticsprivacy-preserving datahealthcare data platformdata de-identificationclinical researchelectronic health recordsEHRhealthcare AIdata democratizationHIPAA complianceself-service analyticsgenAI healthcaredata privacy techprivacy-enhancing technologyPETs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MDClone Comparables

Compare MDClone with similar companies based on industry and business-model similarity.

MDClone comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KPMG
72%
Rhino Health, Inc.
72%
MOSTLY.AI
71%

MDClone Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 1, 2022
Series BAug 22, 2019
Series AFeb 5, 2018
SeedMay 1, 2016
SeedJan 1, 2016

Key People

Founding team and executive leadership

Bruno Lempernesse

Chief Executive Officer

Executive Team

Moran Beeri

Consultant To The CEO

Executive Team

MDClone Investors

Notable investors and investment history

MDClone investors
InvestorRounds
OrbiMedSeries B, Series C, Series A, Seed
aMoonSeries C, Series B
Warburg PincusSeries C
Viola GrowthSeries C
Lightspeed Venture PartnersSeries B, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Launched ADAMS Copilot, a generative AI healthcare data assistant.

  • Oct 28, 2025

    Sponsored and attended the HIMSS Eastern Canada Chapter's 2025 Digital Health Innovation Conference.

MDClone Filings

Explore SEC and related filing metadata, where available.

MDClone filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MDClone's valuation, stock price, and market status.

Is MDClone a public or private company?

MDClone is a private company.

What is the current stock price of MDClone?

MDClone is a private company with no public stock price. No recent secondary market data is available.

How much is MDClone worth (valuation)?

Valuation information for MDClone is not publicly available.

Can I buy MDClone stock?

MDClone shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MDClone's last funding round?

MDClone's most recent funding round was Series C on March 1, 2022.

Who are the main investors in MDClone?

Key investors in MDClone include OrbiMed, aMoon, Warburg Pincus, Viola Growth, Lightspeed Venture Partners.

Will MDClone IPO soon?

No public IPO plans have been announced for MDClone.

How can I track MDClone secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MDClone's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range94
Year Founded2016
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?